Main Article Content

Abstract

Stroke associated pneumonia (SAP) is the most common complication after stroke and has a high mortality rate. SAP mortality profile among Neuro ICU patients has not been fully investigated. Knowledge of mortality profiles can help clinical decision making for patient management. The purpose of this study was to determine the mortality profile of SAP who were treated in the Neuro ICU National Brain Centre (NBC) Hospital. This was a retrospective cohort study of the patients were hospitalized in the Neuro ICU NBC Hospital, who were diagnosed with SAP during 2016-2017. Clinical and laboratory data and the patient's status during treatment are obtained from medical record data. A total of 197 stroke patients who were treated at the Neuro ICU NBC Hospital during 2016-2017, there were 130 (65.98%) patients diagnosed with SAP, with mortality during treatment of 77.7%. The highest SAP mortality was found in male patients (75%), in the age group ≥ 60 years (55.4%), GCS at admission ≤ 8 (88.3%), accompanied by hypertension (66.7%) and leukocytosis (74.8%). In bivariate analysis, the variables that were statistically significant (p <0.05) were hypertension, GCS, LoS, APACHE II score, and PMR.


 


 


 

Keywords

stroke associated pneumonia; mortality profile

Article Details

How to Cite
Ritonga, A., Syarif, S., & Soertidewi, L. (2019). Profil Mortalitas Stroke Associated Pneumonia Tahun 2016-2017. Jurnal Ilmu Dan Teknologi Kesehatan, 6(2), 104-112. https://doi.org/10.32668/jitek.v6i2.172

References

    de Castillo, L. L. C., Sumalapao, D. E. P. and Pascual, J. L. R. 2017. ‘Risk factors for pneumonia in acute stroke patients admitted to the emergency department of a tertiary government hospital’, National Journal of Physiology, Pharmacy and Pharmacology, 7(8), pp. 855–859. doi:10.5455/njppp.2017.7.0411008052017.

    D. Handayani, N. Arief, B. Swidarmoko, P. Astowo, and M. S. D. 2006. ‘Sistem skor acute physiology and chronic health evaluation (APACHE) II sebagai prediksi mortalitas pasien rawat instalasi perawatan intensif’, J Pulmo, 34(1), pp. 36–45.

    Finlayson, O. 2011. ‘Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke’.

    Hannawi, Y. et al. 2013. ‘Stroke-associated pneumonia : Major advances and obstacles’, Cerebrovascular Diseases’, 35(5), pp. 430–443.

    James PA, Oparil S, Carter BL, Cushman WC, Dennison C, Handler J, dkk. 2013. Evidence-based guideline for the management of high blood pressure in adults: Report from the panel member appointed to the eight joint national committee (JNC 8). JAMA; 18 Dec 2013

    Katzan, I. L. et al. 2007. ‘The cost of pneumonia after acute stroke’, Neurology, 68(22), pp. 1938–1943. doi: 10.1212/01.wnl.0000263187.08969.45.

    Nazarian DJ, Eddy OL, Lukens TW, Weingart SD, Decker WW. 2009. Clinical policy: Critical issue in the managenment of adult patients presenting to the emergency departement with community- acquired pneumonia. Ann Emerg Med;54(5):704-29

    Ovbiagele B, Weir CJ, Saver JL, Muir KW. 2006. Effect of smoking status on outcome after acute ischemic stroke. Cerebrovasc Dis.;21:260–5

    Smith, C. J. et al. 2015. ‘Diagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus Group’, Stroke; a journal of cerebral circulation, 46(8), pp. 2335–2340. doi: 10.1161/STROKEAHA.115.009617.

    Wandira RD, Amalia L., Fuadi I. 2018. Hubungan antara derajat keparahan stroke dengan kejadian stroke-associated pneumonia. Neurona ; 35(2)

    Zalacain R, Torres A, Celis R, Blanquer J, Aspa J, Esteban L, et al. 2003. Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur Respir J.;21(2):294-302.